Document Detail


Use of oral gentamicin, metronidazole, and cholestyramine in the treatment of severe persistent diarrhea in infants.
MedLine Citation:
PMID:  3960616     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Oral gentamicin, metronidazole, and cholestyramine were given either as single agents or in various combinations to infants who still required treatment after seven days in the hospital for persistent diarrhea. The effect of these drugs and the interactions between them were assessed by comparing daily stool output during treatment with that in the pretreatment period. The effect of the drugs on apparent nitrogen and fat absorption was also studied. On the first day of treatment the presence of cholestyramine was associated with a significantly greater decrease in stool output. This effect appeared to be largely due to an interaction with gentamicin. Thereafter, only gentamicin produced a significantly greater decrease in stool weight. At no stage was metronidazole of benefit. Gentamicin and cholestyramine also indirectly improved apparent nitrogen and fat absorption by reducing stool output. The combination of oral gentamicin and cholestyramine is recommended as a safe and effective way of treating infants with severe persistent diarrhea following acute gastroenteritis.
Authors:
I D Hill; M D Mann; K C Househam; M D Bowie
Related Documents :
2596276 - Paralytic ileus, a serious complication in acute diarrhoea disease among infants in dev...
14551006 - Rehydration of air-dried cervical smears: a feasible alternative to conventional wet fi...
22729236 - Cohort profile: the china-anhui birth cohort study.
13426796 - Infantile diarrhea; tolerance to solutions of electrolytes by mouth.
17461076 - Toxicity, uptake, and transfer efficiency of fipronil in western subterranean termite (...
11200486 - One-month-old infant with multiple ulcers of stomach, small bowel, large bowel, and pro...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Pediatrics     Volume:  77     ISSN:  0031-4005     ISO Abbreviation:  Pediatrics     Publication Date:  1986 Apr 
Date Detail:
Created Date:  1986-05-05     Completed Date:  1986-05-05     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0376422     Medline TA:  Pediatrics     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  477-81     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cholestyramine Resin / administration & dosage,  therapeutic use*
Diarrhea / drug therapy*,  etiology
Drug Interactions
Drug Therapy, Combination
Gastroenteritis / complications,  drug therapy*
Gentamicins / administration & dosage,  therapeutic use*
Humans
Infant
Intestinal Absorption / drug effects
Lipid Metabolism
Male
Metronidazole / therapeutic use*
Nitrogen / metabolism
Chemical
Reg. No./Substance:
0/Gentamicins; 11041-12-6/Cholestyramine Resin; 443-48-1/Metronidazole; 7727-37-9/Nitrogen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impact of revaccinating children who initially received measles vaccine before 10 months of age.
Next Document:  Childhood enuresis: prevalence, perceived impact, and prescribed treatments.